Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines.
Both the Pfizer-BioNTech and the Moderna shots use part of the virus’s genetic code called messenger RNA, or mRNA, to get the body to recognize the pathogen and attack if a person becomes infected.
What’s more, people will be able to get the new shot every four or five years rather than annually.
‘We actually just completed in the past two weeks the manufacture of a messenger RNA vaccine for influenza that should have broad reactivity across many different strains to make a universal flu vaccine,’ Dr Barton Haynes, director for the Duke Human Vaccine Institute, told Nexstar.
To make flu vaccines, officials from the World Health Organization choose the strains for the Northern Hemisphere’s shot in February, and those for the Southern Hemisphere in September or October.
The flu vaccine comes in the form of a shot or a nasal spray. For those who choose to go with the injectable, there are two options.
The first is a trivalent vaccine, which protects against two influenza A strains, H1N1 and H3N2, and one influenza B strain.
The second option, the quadrivalent flu vaccine, protects against the same strains as the trivalent vaccine, as well as an extra influenza B virus.
For those with egg allergies or who prefer not to have a shot, there is a nasal spray, known as FluMist.
It uses live, weakened viruses which are meant to teach the body to recognize and ward off flu strains if you become infected.
Haynes told Nexstar that, rather than guessing which strains will be prevalent during the season, the new vaccine will be able to target all strains.
Image Credit: Daily Mail
There is no proof that spike proteins created in response to mRNA vaccines are harmful to the body, scientists have told Reuters. The claim was made by immunologist Byram Bridle (here) in an interview [...]
Scientists have worked out how to best get DNA to communicate with membranes in our body, paving the way for the creation of ‘mini biological computers’ in droplets that have potential uses in biosensing [...]
Reactive oxygen species (ROS) exhibit the potential to act as signal carriers during the development of malignant tumors. At a suitable concentration, ROS tends to mediate cell growth and signal transduction. But ROS are [...]
One of the biggest challenges when it comes to probing and manipulating the brain are the blunt tools we have at our disposal. But breakthroughs in nanotechnology could soon change that, say researchers. Neuroscience has [...]
When liquid meets gas, a unique zone forms. Variable by nature, molecules can cross from one state to another, combining in unique ways to either desirable or unwanted ends. From heat escaping a mug [...]
A newly detected coronavirus variant is on the rise in England, with the virus believed to be an offshoot of Delta. According to a briefing from the UK Health Security Agency, released on Friday, [...]
A team of researchers has developed a new nanomechanical technique for fast, one-step, immune-affinity tests, which can quantify the immune response induced by different COVID-19 variants in serum. Their technique provides a new tool [...]
Lawrence Livermore National Laboratory (LLNL) scientists have developed a new method for 3D printing living microbes in controlled patterns, expanding the potential for using engineered bacteria to recover rare-earth metals, clean wastewater, detect uranium, [...]
Nanomedicines may offer clinicians a way to deliver precise, targeted therapy directly to tumors without damaging surrounding tissue. Yet, progress in the development of new drugs that treat cancer at the nanoparticle level has [...]
Cambridge researchers have discovered how T cells—an important component of our immune system—are able keep on killing as they hunt down and kill cancer cells, repeatedly reloading their toxic weapons. Cytotoxic T [...]
Sunday, October 3, set records for the most COVID-19 deaths in Russia on a single day. Only 29% of people in Russia are vaccinated, despite the country being the first to approve a vaccine. [...]
New research from the University of Technology Sydney (UTS) has found that pathogens that form biofilms can evolve to survive nanosilver treatment. The study is the first to demonstrate that long-term nanosilver treatment can [...]
New variants of SARS-CoV-2 are more virulent and transmissible than the original variant of the virus. Health experts associate these variants of concern (VOCs) with increased risk of hospitalization, intensive care unit (ICU) admission, [...]
Freeze-dried genetic circuits could reveal the presence of SARS-CoV-2, Ebola, MRSA, and more. Masks and testing have been key to the COVID-19 pandemic response—and now devices that combine the two may be on the [...]